Terms: = Ovarian cancer AND AXIN2, AXIL, 8313, ENSG00000168646, MGC126582, DKFZp781B0869
21 results:
1. TWIST1 induces proteasomal degradation of β-catenin during the differentiation of ovarian cancer stem-like cells.
Liu J; Shu G; Wu A; Zhang X; Zhou Z; Alvero AB; Mor G; Yin G
Sci Rep; 2022 Sep; 12(1):15650. PubMed ID: 36123378
[TBL] [Abstract] [Full Text] [Related]
2. The expression profile of WNT/β-catanin signalling genes in human oocytes obtained from polycystic ovarian syndrome (PCOS) patients.
Ismail AB; Naji M'S; Nebih İ; Tuncel G; Ozbakir B; Temel SG; Tulay P; Mocan G; Ergoren MC
Zygote; 2022 Aug; 30(4):536-542. PubMed ID: 35357301
[TBL] [Abstract] [Full Text] [Related]
3. Aberrant activation of Wnt/catenin signaling and overexpression of ABCG2 contributes to apoptosis down regulation and tumor progression of high grade ovarian cancer.
Gui Z; Yan H; Wu J; Zhang M; Wu A; He J
Acta Biochim Pol; 2021 Feb; 68(1):127-133. PubMed ID: 33635609
[TBL] [Abstract] [Full Text] [Related]
4. Are developmentally missing teeth a predictive risk marker of malignant diseases in non-syndromic individuals? A systematic review.
Al-Muzian L; Almuzian M; Mohammed H; Ulhaq A; Keightley AJ
J Orthod; 2021 Sep; 48(3):221-230. PubMed ID: 33455496
[TBL] [Abstract] [Full Text] [Related]
5. Tooth agenesis: What do we know and is there a connection to cancer?
Bonczek O; Krejci P; Izakovicova-Holla L; Cernochova P; Kiss I; Vojtesek B
Clin Genet; 2021 Apr; 99(4):493-502. PubMed ID: 33249565
[TBL] [Abstract] [Full Text] [Related]
6. Coexistence of tooth agenesis and ovarian cancer - a systematic literature review.
Gawron-Jakubek W; Spaczynska J; Pitynski K; Loster BW
Ginekol Pol; 2019; 90(12):707-710. PubMed ID: 31909464
[TBL] [Abstract] [Full Text] [Related]
7. Analysis of polymorphisms in genes associated with the FA/BRCA pathway in three patients with multiple primary malignant neoplasms.
Wang L; Wang H; Wang T; Liu J; Chen W; Wang Y; Chen C; Zhu H; Dai P
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1101-1112. PubMed ID: 30942098
[TBL] [Abstract] [Full Text] [Related]
8. Development and validation of HPLC-MS/MS procedure for determination of 3,4,4',5-tetra-methoxystilbene (DMU-212) and its metabolites in ovarian cancer cells and culture medium.
Klupczynska A; Sulej-Suchomska AM; Piotrowska-Kempisty H; Wierzchowski M; Jodynis-Liebert J; Kokot ZJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():30-35. PubMed ID: 28582662
[TBL] [Abstract] [Full Text] [Related]
9. Targeting the Wnt/β-catenin pathway in primary ovarian cancer with the porcupine inhibitor WNT974.
Boone JD; Arend RC; Johnston BE; Cooper SJ; Gilchrist SA; Oelschlager DK; Grizzle WE; McGwin G; Gangrade A; Straughn JM; Buchsbaum DJ
Lab Invest; 2016 Feb; 96(2):249-59. PubMed ID: 26658453
[TBL] [Abstract] [Full Text] [Related]
10. Hypodontia, a prospective predictive marker for tumor?
Yin W; Bian Z
Oral Dis; 2016 May; 22(4):265-73. PubMed ID: 26600092
[TBL] [Abstract] [Full Text] [Related]
11. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.
Wu G; Liu A; Zhu J; Lei F; Wu S; Zhang X; Ye L; Cao L; He S
Oncotarget; 2015 Oct; 6(30):28882-94. PubMed ID: 26337084
[TBL] [Abstract] [Full Text] [Related]
12. CD151-α3β1 integrin complexes suppress ovarian tumor growth by repressing slug-mediated EMT and canonical Wnt signaling.
Baldwin LA; Hoff JT; Lefringhouse J; Zhang M; Jia C; Liu Z; Erfani S; Jin H; Xu M; She QB; van Nagell JR; Wang C; Chen L; Plattner R; Kaetzel DM; Luo J; Lu M; West D; Liu C; Ueland FR; Drapkin R; Zhou BP; Yang XH
Oncotarget; 2014 Dec; 5(23):12203-17. PubMed ID: 25356755
[TBL] [Abstract] [Full Text] [Related]
13. Is there a link between ovarian cancer and tooth agenesis?
Bonds J; Pollan-White S; Xiang L; Mues G; D'Souza R
Eur J Med Genet; 2014 Apr; 57(5):235-9. PubMed ID: 24631698
[TBL] [Abstract] [Full Text] [Related]
14. An analysis of polymorphisms within the Wnt signaling pathway in relation to ovarian cancer risk in a Polish population.
Mostowska A; Pawlik P; Sajdak S; Markowska J; Pawałowska M; Lianeri M; Jagodzinski PP
Mol Diagn Ther; 2014 Feb; 18(1):85-91. PubMed ID: 24078348
[TBL] [Abstract] [Full Text] [Related]
15. The Wnt gatekeeper SFRP4 modulates EMT, cell migration and downstream Wnt signalling in serous ovarian cancer cells.
Ford CE; Jary E; Ma SS; Nixdorf S; Heinzelmann-Schwarz VA; Ward RL
PLoS One; 2013; 8(1):e54362. PubMed ID: 23326605
[TBL] [Abstract] [Full Text] [Related]
16. Wnt and hedgehog gene pathway expression in serous ovarian cancer.
Schmid S; Bieber M; Zhang F; Zhang M; He B; Jablons D; Teng NN
Int J Gynecol Cancer; 2011 Aug; 21(6):975-80. PubMed ID: 21666490
[TBL] [Abstract] [Full Text] [Related]
17. Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer.
Notaridou M; Quaye L; Dafou D; Jones C; Song H; Høgdall E; Kjaer SK; Christensen L; Høgdall C; Blaakaer J; McGuire V; Wu AH; Van Den Berg DJ; Pike MC; Gentry-Maharaj A; Wozniak E; Sher T; Jacobs IJ; Tyrer J; Schildkraut JM; Moorman PG; Iversen ES; Jakubowska A; Mędrek K; Lubiński J; Ness RB; Moysich KB; Lurie G; Wilkens LR; Carney ME; Wang-Gohrke S; Doherty JA; Rossing MA; Beckmann MW; Thiel FC; Ekici AB; Chen X; Beesley J; ; Gronwald J; Fasching PA; Chang-Claude J; Goodman MT; Chenevix-Trench G; Berchuck A; Pearce CL; Whittemore AS; Menon U; Pharoah PD; Gayther SA; Ramus SJ;
Int J Cancer; 2011 May; 128(9):2063-74. PubMed ID: 20635389
[TBL] [Abstract] [Full Text] [Related]
18. Genomic markers for ovarian cancer at chromosomes 1, 8 and 17 revealed by array CGH analysis.
Dimova I; Orsetti B; Negre V; Rouge C; Ursule L; Lasorsa L; Dimitrov R; Doganov N; Toncheva D; Theillet C
Tumori; 2009; 95(3):357-66. PubMed ID: 19688977
[TBL] [Abstract] [Full Text] [Related]
19. Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas.
Sarrió D; Moreno-Bueno G; Sánchez-Estévez C; Bañón-Rodríguez I; Hernández-Cortés G; Hardisson D; Palacios J
Hum Pathol; 2006 Aug; 37(8):1042-9. PubMed ID: 16867867
[TBL] [Abstract] [Full Text] [Related]
20. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.
Wu R; Zhai Y; Fearon ER; Cho KR
Cancer Res; 2001 Nov; 61(22):8247-55. PubMed ID: 11719457
[TBL] [Abstract] [Full Text] [Related]
[Next]
